Miyazato, Paola

HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo

Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., et al. (2011) · PLoS Pathogens

T-cell and Retrovirus StudiesT-cell and B-cell Immunology

Cited by 319

De Novo Human T-Cell Leukemia Virus Type 1 Infection of Human Lymphocytes in NOD-SCID, Common γ-Chain Knockout Mice

Miyazato, P., Yasunaga, J.-I., Taniguchi, Y., Koyanagi, Y., Mitsuya, H., & Matsuoka, M. (2006) · Journal of Virology

T-cell and Retrovirus StudiesViral-associated cancers and disorders

Cited by 54

IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia

Maeda, M., Tanabe-Shibuya, J., Miyazato, P., Masutani, H., Yasunaga, J.-I., Usami, K., Shimizu, A., & Matsuoka, M. (2020) · Frontiers in Microbiology

T-cell and Retrovirus StudiesViral-associated cancers and disorders

Cited by 22

Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity

Yoshida, A., Okamura, S., Torii, S., Komatsu, S., Miyazato, P., Sasaki, H., Ueno, S., Suzuki, H., Kamitani, W., Ono, C., et al. (2022) · iScience

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 20

Versatile live attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity

Yoshida, A., Okamura, S., Torii, S., Komatsu, S., Miyazato, P., Ueno, S., Suzuki, H., Kamitani, W., Ono, C., Matsuura, Y., et al. (2021) · iScience

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 20